Glycosmedia

Diabetes News Service

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookies Policy
  • News
  • Archive
  • Categories & Tags
  • Journal Watch
  • Updates
  • Education
  • Reviews
  • About us ▼
    • About Glycosmedia
    • Editorial Team
    • Frequently asked questions
    • Comments
    • Press Releases
    • Disclaimer
  • Subscribe
  • Contact

Diabetes News

Glycosmedia is dedicated to bringing free, non-promotional, editorially independent news to a global audience about developments in diabetes, and is primarily aimed at health professionals.


Skin collagen glucosepane & past progression microvascular & neuropathy

November 15th 2012

Glucosepane is a novel AGE marker of diabetic complications that is robustly associated with nephropathic, retinopathic and neuropathic outcomes despite adjustment for A1c, suggesting that it could be one mediator of these complications with possible diagnostic implications (Diabetes and Its Complications)

Categories: News, Pathology

Categories: Pathology

Gene Expression Dynamics during Diabetic Periodontitis

November 15th 2012

diabetes-enhanced inflammation both up- and down-regulates genes involved in cellular activity and cell signaling, while it predominantly up-regulates genes involved in the host response, apoptosis, and coagulation/homeostasis/complement and down-regulates mRNA levels of neuron, retina, and energy/metabolism-associated genes (Journal of Dental Research)

Categories: Genetics, News

Categories: Genetics

FORXIGA™ approved in EU for treatment of T2D

November 15th 2012

FORXIGA is a selective and reversible inhibitor of sodium-glucose cotransporter 2 (SGLT2) that works independently of insulin to help remove excess glucose from the body, a unique mode of action not seen in any other currently available treatments for type 2 diabetes (AstraZeneca and Bristol-Myers Squibb)

Categories: Medication, News

Categories: Medication

A Simple Screening Method for Individuals at Risk of Developing T1D

November 13th 2012

Measurement of Islet Cell Autoantibodies (GADA, IA-2A, and IAA) on Dried Capillary Blood Spots Collected on Filter Paper (Human and Metabolic Research)

Categories: News, Screening

Categories: Screening

Long-Acting Insulins Win FDA Panel Support

November 10th 2012

An FDA advisory committee voted 8-4 Thursday in favor of approval of a new ultra-long-acting insulin for type 1 and type 2 diabetes. (medpage TODAY)

Categories: Medication, News

Categories: Medication

Type 2 diabetes: insulin degludec

November 9th 2012

This evidence summary considers the use of insulin degludec in adults with type 2 diabetes (NICE)

Categories: Medication, News

Categories: Medication

Type 1 diabetes: insulin degludec

November 9th 2012

This evidence summary considers the use of insulin degludec in adults with type 1 diabetes (NICE)

Categories: Medication, News

Categories: Medication

The management of adult diabetes services in the NHS

November 8th 2012

Seventeenth Report of Session 2012–13. together with formal minutes, oral and written evidence (House of Commons, UK)

Categories: Audits, News

Categories: Audits

Insulin pharmacodynamic profile & a novel infusion site warming device

November 7th 2012

Our results show that insulin infusion site warming with InsuPatch activation accelerates the time action profile of aspart insulin which may be of benefit to current open-loop and future closed-loop insulin delivery in patients with T1D (Pediatric Diabetes)

Categories: News, Treatment

Categories: Treatment

Cardiovascular Hospitalization in Diabetic Patients on Dialysis

November 7th 2012

Improved glycemic control based on glycated albumin (GA) and plasma glucose predicted CV-related hospitalizations; GA also predicted CV hospitalization length of stay. HbA1c did not predict cause-specific hospitalizations in dialysis populations (American Journal of Nephrology)

Categories: Cardiovascular, News

Categories: Cardiovascular

Carotid-Femoral Pulse Wave Velocity & Cerebral White Matter Lesions T2D

November 7th 2012

PWV was higher among patients with well-controlled type 2 diabetes compared with controls and was independently associated with WMLs. PWV may represent a clinically relevant parameter in the evaluation of cerebrovascular disease risk in type 2 diabetes (Diabetes Care)

Categories: Cardiovascular, News

Categories: Cardiovascular

Professor calls for urgent support for care home ‘silent minority’

November 6th 2012

A leading diabetes expert has called for urgent support for the ‘silent minority’ in care homes to avoid unnecessary suffering and even premature deaths (Institute of Diabetes for Older People)

Categories: News

Categories:

The cost of T1D in the UK: a review of cost-of-illness studies

November 6th 2012

There is no recently published estimate of the cost of Type 1 DM in the UK; therefore, it is recommended that an up-to-date national, comprehensive cost-of-illness study should be conducted. Recommendations for the format of this study are made, including extending the scope to cover recent treatment developments and resource use where diabetes is a subsidiary diagnosis (The European Journal of Health Economics)

Categories: News, Research

Categories: Research

COPD and glucose metabolism: a bitter sweet symphony

November 5th 2012

The current scientific data necessitate a greater outlook on chronic obstructive pulmonary disease and chronic obstructive pulmonary disease may be viewed as a risk factor for the new onset type 2 diabetes mellitus. Conversely, both types of diabetes mellitus should be viewed as strong contributing factors for the development of obstructive lung disease (Cardiovascular Diabetology)

Categories: News, Pathology

Categories: Pathology

Body Mass Index at Diagnosis of AutoimmuneT1D Children

November 5th 2012

Youth who are overweight, obese, racial/ethnic minority, and/or present without diabetic ketoacidosis should not be presumed to have type 2 diabetes because many patients with autoantibody-positive T1D present with the same clinical characteristics (The Journal of Pediatrics)

Categories: News, Screening

Categories: Screening

Strategies for Multivessel Revascularization in Diabetes

November 5th 2012

For patients with diabetes and advanced coronary artery disease, coronary-artery bypass grafting was superior to percutaneous coronary intervention in that it significantly reduced rates of death and myocardial infarction, with a higher rate of stroke (NEJM)

Categories: News, Treatment

Categories: Treatment

Long-Term Consequences Offspring of Paternal Diabetes

November 5th 2012

The offspring of parents with diabetes showed higher proportion of variables related to metabolic syndrome compared with those offspring of healthy parents, and this proportion increased in case of diabetic parents plus metabolic syndrome (Experimental Diabetes Research)

Categories: News, Pathology

Categories: Pathology

Plasma Exposure Insulin Glargine and Metabolites – Subcutaneous Injection

November 2nd 2012

After subcutaneous injection of glargine in male subjects with type 1 diabetes, exposure to glargine is marginal, if any, even at supratherapeutic doses. Glargine is rapidly and nearly completely processed to M1 (21A-Gly-human insulin), which mediates the metabolic effect of injected glargine (Diabetes Care)

Categories: News, Pharmacology

Categories: Pharmacology

Diabetes Death Rates Youths Aged 19 Years and under USA 1968–2009

November 2nd 2012

The trends for diabetes death rates for youths aged

Categories: News

Categories:

Dipeptidyl Peptidase 4 Inhibition may facilitate healing chronic foot ulcers

November 1st 2012

We have showed that DPP-4 inhibition accelerates healing of diabetic chronic ulcer, through induction of a histologic pattern consistent with enhanced angiogenesis. To the best of our knowledge, there has been no study evaluating the vildagliptin effect on the healing of foot ulcers in humans (Experimental Diabetes Research)

Categories: News, Treatment

Categories: Treatment
  • « Previous Page
  • 1
  • …
  • 194
  • 195
  • 196
  • 197
  • 198
  • …
  • 211
  • Next Page »

Subscribe

subscribe-iconFREE weekly updates by email Please CLICK HERE

Platinum Sponsors

Boehringer Ingelheim Lilly

Gold Sponsors

Novo NordiskSanofi DiabetesAstraZenecaNapp Diabetes

Silver Sponsors

Abbott Diabetes CareAmgenWelsh Endocrinology and Diabetes Society (WEDS)About Ascensia Diabetes Care

FUNDING NOTICE

The Glycosmedia website and newsletter has been made possible with funding support from our sponsors. None of our sponsors have control over the content of the website, newsletter, apps, Twitter feed or RSS newsfeed.

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Advertisers

CRC Press

The organisations advertising in this section do not have any input into, or editorial control over the content of this website.

News Archive

calendar-iconNews Archive ››

Categories

  • Audits
  • Bariatric
  • Biochemistry
  • Cardiovascular
  • Devices
  • Diagnosis
  • Diet
  • Education
  • Epidemiology
  • Genetics
  • Gestational
  • Guidance
  • Guidelines
  • Hepatology
  • Hypertension
  • Immunology
  • Management
  • Media
  • Medication
  • Meetings
  • Monitoring
  • Nephrology
  • Neuropathy
  • Nephropathy
  • Obesity
  • Ophthalmology
  • Paediatrics
  • Pathology
  • Pharma
  • Pharmacology
  • Physiology
  • Podiatry
  • Prediabetes
  • Prevalence
  • Prevention
  • Psychological
  • Reports
  • Research
  • Screening
  • Sponsorship
  • Technology
  • Testing
  • Transplantation
  • Treatment
  • Wound Care

To see all articles associated with a category just click on the category name.

Popular Tags

ADA BMI canagliflozin CGM CKD closed-loop COVID-19 dapagliflozin DPP4 elderly Empagliflozin exenatide exercise GLP1 glycaemic control HbA1c heart failure hyperglycemia hypoglycemia incretin insulin insulin pump Insulin resistance Ketoacidosis lada liraglutide metformin microvascular mortality NICE pioglitazone retinopathy semaglutide SGLT2 inhibitors sitagliptin statin sulfonylureas Type 1 Diabetes Type 2 Diabetes Vitamin D

To see all articles associated with a tag just click on the tag name.

Complete list of Tags ››

Recent Book and Product Reviews

  • Oxford Handbook of Emergency Medicine
  • Handbook of Obstetric Medicine
  • Ferri’s Clinical Advisor 2021
  • Oxford Case Histories in Infectious Diseases and Microbiology

Recent Diabetes Updates

  • National Diabetes Audit.
  • Funding bids
  • Publication of Studies During 2016 – Type 2 Diabetes
  • “Attitudes to obesity” findings from the 2015 survey

Join us on Facebook

Join us on Facebook

Please share Glycosmedia:

Follow us on Twitter

My Tweets

mobileGlycosmedia is also available as an App:

For iPhone and iPad | For Android devices


Sponsorship and Advertising

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com


Website by Wired up Wales

Copyright © 2021 Glycosmedia Partnership